Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00198445
Status:
COMPLETED
Last Update Posted:
2013-03-14
First Post:
2005-09-12
Brief Title:
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
Sponsor:
Bausch Lomb Incorporated
Organization:
Bausch Lomb Incorporated
Study Overview
Official Title:
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution 01 vs Placebo for Treatment of Ocular Inflammation Following Cataract Surgery
Status:
COMPLETED
Status Verified Date:
2013-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study was to investigate the efficacy of bromfenac sodium ophthalmic solution 009 for treatment of post-operative ocular inflammation in subjects who undergo cataract extraction and intraocular lens implantation The secondary objective was to investigate the safety and tolerability of the same
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None